-
CLSD Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Clearside Biomedical (CLSD)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 13.89 mm | 13.89 mm | 13.89 mm | 13.89 mm | 13.89 mm | 13.89 mm |
Cash burn (monthly) | 1.45 mm | 1.79 mm | 1.98 mm | 2.05 mm | 1.97 mm | 1.58 mm |
Cash used (since last report) | 6.34 mm | 7.82 mm | 8.65 mm | 8.98 mm | 8.62 mm | 6.90 mm |
Cash remaining | 7.55 mm | 6.07 mm | 5.24 mm | 4.91 mm | 5.27 mm | 6.98 mm |
Runway (months of cash) | 5.2 | 3.4 | 2.6 | 2.4 | 2.7 | 4.4 |
13F holders | Current |
---|---|
Total holders | 51 |
Opened positions | 11 |
Closed positions | 11 |
Increased positions | 8 |
Reduced positions | 13 |
13F shares | Current |
---|---|
Total value | 12.73 bn |
Total shares | 15.46 mm |
Total puts | 50.70 k |
Total calls | 54.70 k |
Total put/call ratio | 0.9 |
Largest owners | Shares | Value |
---|---|---|
Hatteras Venture Advisors III | 3.06 mm | $3.70 mm |
Vanguard | 2.84 mm | $3.61 bn |
Whitmore Bradford T | 2.35 mm | $1.65 mm |
Carmignac Gestion | 1.93 mm | $2.46 bn |
BlackRock | 803.96 k | $1.02 bn |
Renaissance Technologies | 744.89 k | $946.01 mm |
Geode Capital Management | 731.39 k | $929.04 mm |
First Manhattan | 666.14 k | $846.00 mm |
Assenagon Asset Management | 257.10 k | $326.52 mm |
Bridgeway Capital Management | 255.00 k | $323.85 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Jan 25 | Deignan Charles A. | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.97 | 200,000 | 194.00 k | 200,000 |
8 Jan 25 | Ngai Hang Victor Chong | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.97 | 250,000 | 242.50 k | 250,000 |
8 Jan 25 | Lasezkay George M | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.97 | 500,000 | 485.00 k | 500,000 |
1 Nov 24 | Ngai Hang Victor Chong | Common Stock | Buy | Acquire P | No | No | 1 | 36,500 | 36.50 k | 100,000 |
24 Jun 24 | Ngai Hang Victor Chong | Common Stock | Buy | Acquire P | No | No | 1.06 | 23,500 | 24.91 k | 63,500 |